The need for speed in advanced non‐small cell lung cancer: A population kinetics assessment-Reference-Cited by-同舟云学术

The need for speed in advanced non‐small cell lung cancer: A population kinetics assessment

Published:2021-11-11 Issue:24 Volume:10 Page:9040-9046
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Stewart David J.¹^ORCID,Maziak Donna E.²,Moore Sara M.¹,Brule Stephanie Y.¹,Gomes Marcio³,Sekhon Harman³,Dennie Carole⁴,Lo Bryan³,Fung‐Kee‐Fung Michael⁵,Bradford John‐Peter⁶,Reaume Martin Neil¹

Affiliation:

1. Department of Medicine University of Ottawa Ottawa Ontario Canada

2. Department of Surgery University of Ottawa Ottawa Ontario Canada

3. Department of Pathology University of Ottawa Ottawa Ontario Canada

4. Department of Diagnostic Imaging University of Ottawa Ottawa Ontario Canada

5. Department of Obstetrics and Gynecology University of Ottawa Ottawa Ontario Canada

6. Life Saving Therapies Network Ottawa Ontario Canada

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4411

Reference30 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

2. Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors

3. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

4. First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

5. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of next-generation sequencing vs polymerase chain reaction testing on payer costs and clinical outcomes throughout the treatment journeys of patients with metastatic non–small cell lung cancer;Journal of Managed Care & Specialty Pharmacy;2024-09-11

2. Point of Care Liquid Biopsy for Cancer Treatment—Early Experience from a Community Center;Cancers;2024-07-10

3. Has the blood-brain barrier finally been busted?;The Oncologist;2024-06-05

4. Population Survival Kinetics Derived from Clinical Trials of Potentially Curable Lung Cancers;Current Oncology;2024-03-20

5. Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer;Journal of Medical Economics;2024-02-24